Ctnna2 Antibody

What is CTNNA2 and why is it an important research target?

CTNNA2, also known as α-catenin 2, plays a crucial role in cell-cell adhesion and signaling pathways. It functions as a linker between cadherin adhesion receptors and the cytoskeleton to regulate cell-cell adhesion and differentiation, particularly in the nervous system. Its dysregulation has been implicated in various diseases, including cancer and neurological disorders, making it an important target for research in these areas . CTNNA2 is required for proper regulation of cortical neuronal migration and neurite growth, acting as a negative regulator of Arp2/3 complex activity and Arp2/3-mediated actin polymerization .

What applications are most effective for CTNNA2 antibody detection?

CTNNA2 antibodies have been validated for multiple applications with varying efficacy:

• Western Blot (WB): Effective at dilutions ranging from 1:200-1:2000, depending on the specific antibody

• Immunohistochemistry (IHC-P): Typically used at 1:50-1:200 dilution

• Immunofluorescence/Immunocytochemistry (IF/ICC): Optimal at 1:50-1:200 dilution

• ELISA: Validated for quantitative detection

• Immunoprecipitation (IP): Effective when paired with appropriate detection antibodies

What sample types have been verified for CTNNA2 antibody reactivity?

Different CTNNA2 antibodies show reactivity with various species and sample types:

Why does the observed molecular weight of CTNNA2 often differ from calculated predictions?

The calculated molecular weight of CTNNA2 varies between 59-105 kDa, but the observed MW in Western blot is frequently around 120 kDa . This discrepancy occurs because:

• Post-translational modifications can alter protein mobility

• Different protein isoforms may be present simultaneously

• The complex structure of CTNNA2 can affect migration rate in gel electrophoresis

• Sample preparation methods may influence protein conformation

Researchers should validate the specificity of bands using appropriate positive controls such as mouse brain or rat brain lysates, which are known to express CTNNA2 .

How should CTNNA2 antibodies be stored to maintain optimal activity?

To maintain CTNNA2 antibody efficacy:

• Store at -20°C or lower (as recommended by manufacturers)

• Aliquot to avoid repeated freeze-thaw cycles, which can degrade antibody quality

• Return reagents to -20°C storage immediately after use

• Most preparations are supplied in phosphate buffered solution (pH 7.4) containing stabilizers and 50% glycerol

• Antibodies typically remain valid for 12 months when stored properly

What controls are essential when validating CTNNA2 antibody specificity?

When establishing CTNNA2 antibody specificity:

• Positive tissue controls: Mouse brain, rat brain, rat liver, and mouse testis are recommended

• Cellular controls: MCF7 and Neuro-2a cell lines express detectable levels of CTNNA2

• Negative controls: Include secondary antibody-only controls and tissues known not to express CTNNA2

• Antibody validation: Consider using CTNNA2 knockout or knockdown samples when available

• Peptide competition: Pre-incubation with immunizing peptide should abolish specific signals

How can researchers optimize immunoprecipitation of CTNNA2 for protein interaction studies?

For effective CTNNA2 immunoprecipitation:

• Use specialized IP-WB antibody pairs designed for this purpose, such as rabbit polyclonal anti-CTNNA2 for IP combined with mouse purified polyclonal anti-CTNNA2 for detection

• Employ Protein A Magnetic Beads (e.g., U0007) for efficient pulldown of rabbit antibodies

• Optimize lysis buffer conditions to preserve protein-protein interactions (typically RIPA or NP-40 based buffers with protease inhibitors)

• Perform pre-clearing of lysates to reduce non-specific binding

• Include appropriate washing steps to remove non-specific interactions while preserving genuine binding partners

• Validate results with reverse immunoprecipitation using antibodies against suspected binding partners

What methodological approaches can reveal CTNNA2's role in neuronal development?

To investigate CTNNA2's function in neuronal contexts:

• Combine ICC/IF with neuronal markers to track CTNNA2 localization during development

• Use time-course experiments in primary neuronal cultures to monitor CTNNA2 expression during neurite growth

• Employ high-resolution imaging techniques to visualize CTNNA2 at adherens junctions and actin-rich structures

• Design experiments to measure Arp2/3 complex activity in the presence and absence of CTNNA2 to confirm its role as a negative regulator

• Utilize tissue-specific conditional knockout models to assess developmental abnormalities in cerebellar and hippocampal lamination

How can researchers distinguish between different CTNNA2 subcellular localizations?

CTNNA2 exhibits multiple subcellular localizations including cytoplasm, cytoskeleton, cell junctions, cell membrane, axons, and potentially the nucleus upon ZNF639 overexpression . To distinguish between these:

• Perform subcellular fractionation followed by Western blot analysis

• Use co-immunofluorescence with markers for specific compartments:

  • β-catenin or E-cadherin for adherens junctions

  • Phalloidin for actin cytoskeleton

  • Tau or MAP2 for axonal projections

  • Nuclear markers when studying ZNF639-induced nuclear translocation

• Employ super-resolution microscopy for precise localization studies

• Consider electron microscopy with immunogold labeling for ultrastructural localization

What experimental designs are appropriate for studying CTNNA2 in neurological disorders?

CTNNA2 has been implicated in Cortical Dysplasia, Complex, With Other Brain Malformations 9 . Research approaches include:

• Immunohistochemical comparison of CTNNA2 expression patterns between normal and pathological brain tissues

• Analysis of CTNNA2 mutations in patient samples using sequencing followed by antibody-based functional studies

• Development of in vitro models using patient-derived cells to study CTNNA2 localization and function

• Correlation of CTNNA2 expression levels with neuronal migration defects using quantitative imaging techniques

• Integration of CTNNA2 antibody staining with other markers of cortical development to establish mechanistic insights

How can CTNNA2 antibodies contribute to cancer research methodologies?

For cancer-related CTNNA2 research:

• Perform tissue microarray analysis using anti-CTNNA2 antibodies to assess expression patterns across multiple tumor types

• Combine with markers of epithelial-mesenchymal transition to study CTNNA2's role in cancer progression

• Use CTNNA2 antibodies to monitor changes in cell-cell adhesion properties during tumor formation

• Conduct proteomic studies using immunoprecipitation to identify cancer-specific CTNNA2 interaction partners

• Evaluate CTNNA2 as a potential biomarker by correlating expression levels with clinical outcomes

What methodological approaches can reveal CTNNA2's interaction with the Arp2/3 complex?

To study CTNNA2's role as a negative regulator of Arp2/3 complex:

• Perform co-immunoprecipitation experiments using CTNNA2 antibodies followed by Western blot for Arp2/3 components

• Combine with in vitro actin polymerization assays to measure the functional impact on branched actin network formation

• Use proximity ligation assays to visualize direct interactions between CTNNA2 and Arp2/3 components in situ

• Develop FRET-based biosensors to monitor CTNNA2-Arp2/3 interactions in live cells

• Design domain-specific antibodies to map the regions of CTNNA2 responsible for Arp2/3 regulation

How can multiplexed antibody techniques advance CTNNA2 functional studies?

Advanced multiplexed approaches for CTNNA2 research:

• Combine CTNNA2 antibodies with antibodies against other cell adhesion molecules for comprehensive pathway analysis

• Employ cyclic immunofluorescence or mass cytometry for highly multiplexed single-cell analysis

• Utilize conjugation-ready antibody formats that can be labeled with fluorochromes, metal isotopes, or oligonucleotides for advanced applications

• Integrate spatial transcriptomics with CTNNA2 protein localization data

• Apply machine learning algorithms to extract patterns from complex multiplexed datasets

What considerations should researchers make when selecting between polyclonal and monoclonal CTNNA2 antibodies?

When choosing between antibody types:

Select based on experimental goals, required specificity, and the importance of reproducibility across experiments .